141 related articles for article (PubMed ID: 28066958)
1. Comparison of patient-derived high and low phosphatidylserine-exposing colorectal carcinoma cells in their interaction with anti-cancer peptides.
Wilms D; Andrä J
J Pept Sci; 2017 Jan; 23(1):56-67. PubMed ID: 28066958
[TBL] [Abstract][Full Text] [Related]
2. The NK-lysin derived peptide NK-2 preferentially kills cancer cells with increased surface levels of negatively charged phosphatidylserine.
Schröder-Borm H; Bakalova R; Andrä J
FEBS Lett; 2005 Nov; 579(27):6128-34. PubMed ID: 16269280
[TBL] [Abstract][Full Text] [Related]
3. Influence of the bilayer composition on the binding and membrane disrupting effect of Polybia-MP1, an antimicrobial mastoparan peptide with leukemic T-lymphocyte cell selectivity.
dos Santos Cabrera MP; Arcisio-Miranda M; Gorjão R; Leite NB; de Souza BM; Curi R; Procopio J; Ruggiero Neto J; Palma MS
Biochemistry; 2012 Jun; 51(24):4898-908. PubMed ID: 22630563
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive lipid binding and activity validation of a cancer-specific peptide-peptoid hybrid PPS1.
Desai TJ; Udugamasooriya DG
Biochem Biophys Res Commun; 2017 Apr; 486(2):545-550. PubMed ID: 28322795
[TBL] [Abstract][Full Text] [Related]
5. Design of NK-2-derived peptides with improved activity against equine sarcoid cells.
Gross S; Wilms D; Krause J; Brezesinski G; Andrä J
J Pept Sci; 2013 Oct; 19(10):619-28. PubMed ID: 23893605
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylserine lipids and membrane order precisely regulate the activity of Polybia-MP1 peptide.
Alvares DS; Ruggiero Neto J; Ambroggio EE
Biochim Biophys Acta Biomembr; 2017 Jun; 1859(6):1067-1074. PubMed ID: 28274844
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis for membrane selectivity of NK-2, a potent peptide antibiotic derived from NK-lysin.
Schröder-Borm H; Willumeit R; Brandenburg K; Andrä J
Biochim Biophys Acta; 2003 Jun; 1612(2):164-71. PubMed ID: 12787934
[TBL] [Abstract][Full Text] [Related]
8. Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine.
Riedl S; Leber R; Rinner B; Schaider H; Lohner K; Zweytick D
Biochim Biophys Acta; 2015 Nov; 1848(11 Pt A):2918-31. PubMed ID: 26239537
[TBL] [Abstract][Full Text] [Related]
9. Structure-based design of peptides against HER2 with cytotoxicity on colon cancer.
Cha N; Han X; Jia B; Liu Y; Wang X; Gao Y; Ren J
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):649-654. PubMed ID: 27068253
[TBL] [Abstract][Full Text] [Related]
10. Melanoma cell surface-expressed phosphatidylserine as a therapeutic target for cationic anticancer peptide, temporin-1CEa.
Wang C; Chen YW; Zhang L; Gong XG; Zhou Y; Shang DJ
J Drug Target; 2016; 24(6):548-56. PubMed ID: 26596643
[TBL] [Abstract][Full Text] [Related]
11. Isoleucine/leucine residues at "a" and "d" positions of a heptad repeat sequence are crucial for the cytolytic activity of a short anticancer lytic peptide.
Fan R; Yuan Y; Zhang Q; Zhou XR; Jia L; Liu Z; Yu C; Luo SZ; Chen L
Amino Acids; 2017 Jan; 49(1):193-202. PubMed ID: 27778166
[TBL] [Abstract][Full Text] [Related]
12. The elimination of P-glycoprotein over-expressing cancer cells by antimicrobial cationic peptide NK-2: the unique way of multi-drug resistance modulation.
Banković J; Andrä J; Todorović N; Podolski-Renić A; Milošević Z; Miljković D; Krause J; Ruždijić S; Tanić N; Pešić M
Exp Cell Res; 2013 Apr; 319(7):1013-27. PubMed ID: 23298945
[TBL] [Abstract][Full Text] [Related]
13. Secretory Expression of a Chimeric Peptide in Lactococcus lactis: Assessment of its Cytotoxic Activity and a Deep View on Its Interaction with Cell-Surface Glycosaminoglycans by Molecular Modeling.
Tanhaeian A; Jaafari MR; Ahmadi FS; Vakili-Ghartavol R; Sekhavati MH
Probiotics Antimicrob Proteins; 2019 Sep; 11(3):1034-1041. PubMed ID: 30552573
[TBL] [Abstract][Full Text] [Related]
14. Apoptotic human neutrophil peptide-1 anti-tumor activity revealed by cellular biomechanics.
Gaspar D; Freire JM; Pacheco TR; Barata JT; Castanho MA
Biochim Biophys Acta; 2015 Feb; 1853(2):308-16. PubMed ID: 25447543
[TBL] [Abstract][Full Text] [Related]
15. On the selectivity and efficacy of defense peptides with respect to cancer cells.
Harris F; Dennison SR; Singh J; Phoenix DA
Med Res Rev; 2013 Jan; 33(1):190-234. PubMed ID: 21922503
[TBL] [Abstract][Full Text] [Related]
16. Anticancer peptide SVS-1: efficacy precedes membrane neutralization.
Gaspar D; Veiga AS; Sinthuvanich C; Schneider JP; Castanho MA
Biochemistry; 2012 Aug; 51(32):6263-5. PubMed ID: 22839778
[TBL] [Abstract][Full Text] [Related]
17. Interaction of two antitumor peptides with membrane lipids - Influence of phosphatidylserine and cholesterol on specificity for melanoma cells.
Wodlej C; Riedl S; Rinner B; Leber R; Drechsler C; Voelker DR; Choi JY; Lohner K; Zweytick D
PLoS One; 2019; 14(1):e0211187. PubMed ID: 30682171
[TBL] [Abstract][Full Text] [Related]
18. Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane.
Dai Y; Cai X; Shi W; Bi X; Su X; Pan M; Li H; Lin H; Huang W; Qian H
Amino Acids; 2017 Sep; 49(9):1601-1610. PubMed ID: 28664269
[TBL] [Abstract][Full Text] [Related]
19. New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cells.
Papo N; Shai Y
Biochemistry; 2003 Aug; 42(31):9346-54. PubMed ID: 12899621
[TBL] [Abstract][Full Text] [Related]
20. PE and PS Lipids Synergistically Enhance Membrane Poration by a Peptide with Anticancer Properties.
Leite NB; Aufderhorst-Roberts A; Palma MS; Connell SD; Ruggiero Neto J; Beales PA
Biophys J; 2015 Sep; 109(5):936-47. PubMed ID: 26331251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
